537
Reference
Anderson, J. W., Johnstone, B. M., and Cook-Newell, M. E. (1995). Meta-analysis of the effects of soy protein
intake on serum lipids.
New England Journal of Medicine.
333, 276-282.
Azadbakht, L., Atabak, S., and Esmaillzadeh, A. (2008). Soy protein intake, carchorenal indices, and C-reactive
protein in type 2 diabetes with nephropathy - A longitudinal randomized clinical trial.
Diabetes Care.
31(4), 648-654.
Azadbakht, L., Kimiagar, M., Mehrabi, Y., Esmaillzadeh, A., Hu, F. B., and Willett, W. C. (2007). Soy
consumption, markers of inflammation, and endothelial function - A cross-over study in postmenopausal
women with the metabolic syndrome.
Diabetes Care.
30(4), 967-973.
Comming, D. M., King, D. E., Mainous, A. G., and Gessey, M. E. (2005). Combining serum biomarkers: the
association of C-raactive protein, insulin sensitivity, and homocysteine with cardiovascular disease
history in the general US population.
European Journal of Cardivascular Prevention and
Rehabilitation.
13, 180-185.
Erdman, J. W. 2000. Soy protein and cardiovascualr disease: A statement for healthcare professionals from the
nutrition committee of the AHA.
Circulation
102: 2555-2559.
Fukuhara, M., Matsumura, K., Wakisaka, M., Takata, Y., Sonoki, K., Fujisawa, K., et al. (2006). Hyperglycemia
promotes microinflammation as evaluated by C-reactive protein in the very elderly.
Internal Medicine
Journal
. 307-312.
Gonzalez-Clemente, J. M., Deulofeu, R., Mitjavila, J., Galdon, G., Ortega, E., Caixas, A., et al. (2002). Plasma
homocysteine is not increased in microalbuminuric patients with type 2 diabetes without clinical
cardiovascular disease.
Diabetes Care.
25(3), 632-634.
Gonzalez, S., Jayagopal, V., Kilpatrick, E. S., Chapman, T., and Atkin, S. L. (2007). Effects of isoflavone dietary
supplementation on cardiovascular risk factors in type 2 diabetes.
Diabetes Care.
30(7), 1871-1873.
Jayagopal, V., Albertazzi, P., Kilpatrick, E. S., Howarth, E., Jennings, P. E., Hepburn, D. A., et al. (2002). Dietary
soy phytoestrogen intake reduces insulin resistance and improves glycaemic control in postmenopausal
women with type 2 diabetes.
Diabetes Care
. 51, A139-A139.
Khan, D. A., and Qayyum, S. (2009). Evalution of cardiac risk by oxidative stress and inflammatory markers in
diabetic patients. [Article].
Pakistan Journal of Medical Sciences
. 25(5), 776-781.
Marini, H., Bitto, A., Altavilla, D., Burnett, B. P., Polito, F., Di Stefano, V., et al. (2010). Efficacy of genistein
aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study.
Nutrition,
Metabolism and Cardiovascular Diseases.
20(5), 332-340.
Maskarinec, G., Steude, J. S., Franke, A. A., and Cooney, R. V. (2009). Inflammatory markers in a 2-year soy
intervention among premenopausal women.
Journal of Inflammation-London.
6, 1-7.
